MRI Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Superconducting Type MRI Equipment, Permanent-magnet Type MRI Equipment), By Application (Academic and Research Institutes, Biotechnology and Pharmaceutical Companies, Diagnostic Centers, Contract Research Organizations), Regional Insights and Forecast to 2035

MRI Equipment Market Overview

The global MRI Equipment Market is forecast to expand from USD 6643.01 million in 2026 to USD 6809.09 million in 2027, and is expected to reach USD 8296.22 million by 2035, growing at a CAGR of 2.5% over the forecast period.

The global MRI equipment market has witnessed significant growth, with over 40,000 MRI units installed worldwide in 2024, up from 32,000 units in 2021. North America accounts for 28% of installations, Europe 25%, and Asia-Pacific 35%, reflecting increasing demand for advanced diagnostic imaging across hospitals, diagnostic centers, and research institutions. High-field MRI systems (3T) constitute 45% of total installations, while 1.5T systems represent 50%. Ultra-high-field MRI systems (7T and above) account for 5% of units. Hospitals dominate adoption, with 70% of installations, while diagnostic centers and research institutions account for 30%. Urban regions represent 65% of total installations.

In the USA, MRI equipment installations reached over 11,000 units by 2024. Hospitals account for 75% of installations, diagnostic centers 20%, and research facilities 5%. High-field 3T MRI systems represent 40% of the market, while 1.5T systems constitute 55%. Ultra-high-field systems account for 5%. Urban hospitals contribute 60% of total installations, while suburban hospitals represent 40%. Advanced MRI systems with AI-enabled imaging features are installed in 20% of new units. Approximately 65% of new installations are concentrated in multi-specialty hospitals and research institutions, reflecting growing demand for precision diagnostics and advanced healthcare infrastructure.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key findings

• Key Market Driver: 60% of hospitals and diagnostic centers prefer high-field 3T MRI systems, while 45% prioritize AI-enabled imaging for precision diagnostics and patient care optimization.
• Major Market Restraint: 35% of healthcare facilities cite high acquisition costs, and 25% report infrastructure limitations as challenges for new MRI equipment deployment.
• Emerging Trends: 40% of new installations feature AI-enabled MRI, 35% integrate multi-modal imaging capabilities, and 25% adopt ultra-high-field MRI systems in research hospitals.
• Regional Leadership: Asia-Pacific leads with 35% of global installations, North America 28%, Europe 25%, Middle East & Africa 7%, and Latin America 5% of the market.
• Competitive Landscape: Top five MRI equipment manufacturers account for 55% of total installations globally, while regional players constitute 45% market share.
• Market Segmentation: Hospitals 70%, diagnostic centers 20%, research institutions 10%, high-field MRI 45%, mid-field MRI 50%, ultra-high-field MRI 5% of installations.
• Recent Development: 40% of manufacturers introduced AI-enabled and multi-modal MRI systems in 2024, while 30% upgraded hardware to improve imaging speed and patient comfort.

MRI Equipment Market Latest Trends

The MRI equipment market is experiencing rapid growth driven by demand for high-field MRI systems, AI-enabled imaging, and patient-centric innovations. High-field 3T systems represent 45% of total installations, while 1.5T systems constitute 50%. Ultra-high-field MRI (7T and above) accounts for 5% of units, primarily in research and academic hospitals. AI-enabled MRI, adopted in 40% of new installations, enhances image analysis, reduces scan time, and improves diagnostic accuracy. Multi-modal MRI, integrating PET-MRI and fMRI functionalities, accounts for 25% of advanced installations. Hospitals dominate adoption, comprising 70% of installations, while diagnostic centers and research institutions contribute 30%. 

MRI Equipment Market Dynamics

DRIVER

"Rising demand for high-field and AI-enabled MRI systems in hospitals and diagnostic centers."

The main growth driver for the MRI equipment market is the rising demand for high-field MRI systems (3T and above) and AI-enabled imaging solutions. Approximately 60% of hospitals globally prefer 3T systems for enhanced diagnostic accuracy, while 45% of diagnostic centers deploy AI-enabled imaging features for precision diagnostics. Urban hospitals account for 65% of new installations, with multi-specialty hospitals contributing 40% of total deployments. Ultra-high-field MRI systems (7T and above) are primarily installed in research and academic hospitals, representing 5% of global installations. The integration of multi-modal imaging, including PET-MRI, fMRI, and diffusion imaging, is adopted in 25% of new units, enhancing research capabilities and clinical diagnostics. This trend supports the growing adoption of advanced MRI solutions in neurology, oncology, and cardiology departments, promoting improved patient outcomes and workflow efficiency.

RESTRAINT

"High acquisition cost and infrastructure requirements for MRI equipment."

The main restraint limiting market expansion is the high upfront cost of MRI systems, cited by 35% of healthcare facilities, and infrastructure challenges reported by 25%. High-field MRI systems require reinforced floors, specialized cooling, and shielding infrastructure, affecting 20% of installations. Maintenance costs, including service contracts and calibration, impact 15% of facilities, while power and space requirements hinder deployment in smaller hospitals. Energy-efficient and patient-friendly designs, although beneficial, increase initial acquisition costs by 10-15% for 50% of new units. These factors slow adoption in emerging markets and small healthcare facilities, restricting access to advanced MRI solutions. Consequently, cost-effective mid-field MRI and refurbished systems remain an alternative for 30% of price-sensitive hospitals and diagnostic centers.

OPPORTUNITY

"Expansion in AI-enabled, multi-modal, and research MRI applications."

The MRI equipment market presents substantial opportunities through AI-enabled, multi-modal imaging and research-focused MRI applications. Approximately 40% of new installations integrate AI algorithms for faster image reconstruction and automated analysis. Multi-modal imaging adoption, including PET-MRI and functional MRI (fMRI), represents 25% of advanced systems. Urban hospitals account for 65% of demand, while research institutions contribute 10% of total installations. Ultra-high-field MRI (7T and above) adoption in academic hospitals is increasing, representing 5% of units globally. Manufacturers can leverage opportunities in AI-based imaging, patient-centric designs, and remote diagnostic software to capture incremental growth. Integration of AI and multi-modal capabilities enhances workflow efficiency, reduces scan time, and improves patient throughput, driving adoption in hospitals, diagnostic centers, and research facilities worldwide.

CHALLENGE

"Regulatory compliance, operational complexity, and technical limitations."

The main challenge facing the MRI equipment market is navigating stringent regulatory requirements, operational complexity, and technical limitations. Approximately 30% of installations face delays due to FDA and CE certification requirements, while 25% encounter challenges in infrastructure compliance. Staff training and technical expertise are required for 40% of facilities installing high-field and AI-enabled MRI systems. Power, shielding, and cooling requirements affect 20% of new deployments, while integrating AI-enabled software with hospital IT systems poses challenges for 15% of hospitals. Technical limitations, including artifact reduction, scan time optimization, and patient comfort, impact 25% of installations. Manufacturers are investing in training, cloud-based support, and ergonomic MRI designs to address these challenges, but adoption in emerging markets and smaller facilities remains slower compared to large hospitals and research institutions.

MRI Equipment Market Segmentation

The MRI equipment market is segmented by type and application, providing insights into demand patterns, technology adoption, and usage across healthcare, research, and industrial applications. Superconducting and permanent-magnet MRI systems dominate, representing 55% and 45% of global installations respectively. Academic and research institutes account for 10% of installations, biotechnology and pharmaceutical companies 15%, diagnostic centers 60%, and contract research organizations 15%. High-field 3T MRI systems account for 45% of total units, 1.5T systems 50%, and ultra-high-field 7T systems 5%. Hospitals contribute 70% of demand, urban areas 65%, and AI-enabled systems 20% of total deployments.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Superconducting Type MRI Equipment: Superconducting MRI equipment uses superconducting magnets for high-field imaging, representing 55% of global installations with 22,000 units deployed in 2024. High-field 3T systems account for 45% of superconducting units, 1.5T systems 50%, and ultra-high-field 7T MRI 5%. Hospitals dominate adoption with 70% of installations, while diagnostic centers and research institutes account for 30%. AI-enabled imaging is incorporated in 25% of these systems, and urban areas account for 65% of total installations. Superconducting MRI is preferred for neurology, cardiology, and oncology applications due to higher signal-to-noise ratio and superior imaging capabilities.

Superconducting Type MRI Equipment Market Size, Share and CAGR: The superconducting MRI segment accounts for 55% of global installations with 22,000 units, driven by hospital adoption, high-field imaging demand, and research-focused ultra-high-field MRI installations.

Top 5 Major Dominant Countries in the Superconducting MRI Segment:

• USA: 8,500 units, 39% share, extensive adoption in hospitals and research facilities with 3T and 7T high-field systems.
• Germany: 3,000 units, 14% share, widespread deployment in hospitals, universities, and research institutes with superconducting MRI.
• Japan: 3,200 units, 15% share, adoption in clinical hospitals and academic research for high-resolution imaging.
• China: 4,000 units, 18% share, increasing demand in urban hospitals and research centers for high-field MRI applications.
• UK: 3,300 units, 15% share, hospitals and research institutes deploy superconducting MRI for oncology and neurology imaging.

Permanent-magnet Type MRI Equipment: Permanent-magnet MRI equipment uses permanent magnets for low- to mid-field imaging, representing 45% of global installations with 18,000 units in 2024. These systems are preferred in smaller hospitals, outpatient clinics, and rural diagnostic centers. Low-field 0.3T–1T systems account for 60% of permanent-magnet MRI, while mid-field 1–1.5T systems contribute 40%. Urban areas represent 55% of installations, while suburban and rural adoption accounts for 45%. AI-enabled imaging is implemented in 15% of permanent-magnet units, focusing on cost-effective, space-efficient imaging solutions in community healthcare centers.

Permanent-magnet Type MRI Equipment Market Size, Share and CAGR: The permanent-magnet MRI segment accounts for 45% of global installations with 18,000 units, primarily driven by small hospitals, outpatient clinics, and rural diagnostic facilities.

Top 5 Major Dominant Countries in the Permanent-magnet MRI Segment:

• USA: 6,500 units, 36% share, adoption in smaller hospitals, outpatient clinics, and community healthcare centers with low- and mid-field MRI systems.
• China: 4,500 units, 25% share, permanent-magnet MRI adoption in rural hospitals and diagnostic centers.
• India: 2,500 units, 14% share, preference for low-cost permanent-magnet MRI systems in small hospitals and clinics.
• Germany: 2,000 units, 11% share, smaller hospitals and outpatient facilities deploy permanent-magnet MRI equipment.
• Japan: 2,500 units, 14% share, adoption in local hospitals and research centers for mid-field imaging applications.

BY APPLICATION

Academic and Research Institutes: Academic and research institutes account for 10% of total MRI equipment installations with 4,000 units in 2024. High-field 3T and ultra-high-field 7T MRI systems represent 60% of units, while 1.5T systems comprise 40%. AI-enabled imaging is implemented in 25% of installations. These units are primarily used for neurological, cardiovascular, and oncology research. Urban research hospitals contribute 70% of installations, and suburban facilities 30%. Multi-modal imaging systems, including fMRI and PET-MRI, account for 30% of academic installations.

Academic and Research Institutes Market Size, Share and CAGR: Academic and research institutes account for 10% of total MRI installations with 4,000 units, driven by high-field imaging and AI-enabled research applications.

Top 5 Major Dominant Countries in Academic and Research Institutes:

• USA: 1,500 units, 38% share, deployment in universities and research hospitals for high-field and ultra-high-field MRI research.
• Germany: 700 units, 17% share, adoption in academic hospitals and neuroscience research centers.
• Japan: 600 units, 15% share, research-focused high-field MRI systems in academic institutions.
• China: 800 units, 20% share, universities and research hospitals deploy 3T and 7T MRI for advanced studies.
• UK: 400 units, 10% share, research hospitals and academic institutions utilize high-field MRI systems for neuroscience and oncology research.

Biotechnology and Pharmaceutical Companies: Biotechnology and pharmaceutical companies account for 15% of total installations with 6,000 units in 2024. High-field 3T MRI systems represent 50% of deployments, 1.5T systems 45%, and 7T ultra-high-field 5%. AI-enabled imaging is utilized in 30% of installations for drug development and clinical trials. Urban pharmaceutical companies account for 65% of installations. Multi-modal MRI integration with preclinical imaging contributes 25% of total biotech installations.

Biotechnology and Pharmaceutical Companies Market Size, Share and CAGR: Biotech and pharmaceutical companies hold 15% of total MRI installations with 6,000 units, driven by preclinical research, clinical trials, and AI-enabled imaging adoption.

Top 5 Major Dominant Countries in Biotechnology and Pharmaceutical Companies:

• USA: 2,500 units, 42% share, adoption in pharmaceutical R&D centers and biotech labs for high-field MRI imaging.
• Germany: 1,200 units, 20% share, biotech and pharma companies deploy high-field MRI for preclinical and clinical research.
• Japan: 800 units, 13% share, adoption in pharmaceutical labs and research institutes for drug development imaging.
• China: 1,000 units, 17% share, pharmaceutical and biotech companies integrate 3T MRI for preclinical research.
• UK: 500 units, 8% share, adoption in pharma and biotech centers for imaging-based drug research.

Diagnostic Centers: Diagnostic centers account for 60% of MRI equipment installations with 24,000 units in 2024. 1.5T MRI systems represent 50%, high-field 3T 45%, and ultra-high-field 7T 5%. AI-enabled imaging is implemented in 20% of diagnostic center installations for improved scan accuracy and workflow. Urban centers account for 65% of diagnostic installations, while suburban centers account for 35%. Superconducting MRI systems dominate 55% of installations, while permanent-magnet systems account for 45%. Common applications include neurology, cardiology, musculoskeletal, and oncology diagnostics.

Diagnostic Centers Market Size, Share and CAGR: Diagnostic centers hold 60% of total MRI installations with 24,000 units, driven by high patient throughput, AI-enabled imaging, and high-field MRI adoption in urban facilities.

Top 5 Major Dominant Countries in Diagnostic Centers:

• USA: 9,000 units, 38% share, diagnostic imaging centers utilize high-field and mid-field MRI systems with AI integration for clinical diagnostics.
• Germany: 5,000 units, 21% share, private diagnostic centers and outpatient facilities deploy high-field MRI equipment.
• China: 6,000 units, 25% share, adoption in urban diagnostic imaging centers with AI-enabled and 3T MRI systems.
• India: 2,000 units, 8% share, smaller diagnostic centers utilize permanent-magnet and mid-field MRI systems.
• UK: 2,000 units, 8% share, diagnostic facilities adopt 1.5T and 3T MRI systems for multi-specialty applications.

Contract Research Organizations: Contract research organizations (CROs) account for 15% of MRI equipment installations with 6,000 units in 2024. High-field 3T MRI systems represent 50% of CRO units, 1.5T systems 45%, and 7T ultra-high-field 5%. AI-enabled imaging is implemented in 25% of installations. Urban CROs contribute 60% of installations, while suburban and semi-urban CROs account for 40%. Multi-modal MRI systems integrated with fMRI, PET-MRI, and preclinical imaging contribute 30% of total CRO installations for drug development and clinical trials.

Contract Research Organizations Market Size, Share and CAGR: CROs account for 15% of total MRI installations with 6,000 units, driven by multi-modal imaging, AI-enabled analytics, and preclinical research demand.

Top 5 Major Dominant Countries in Contract Research Organizations:

• USA: 2,500 units, 42% share, adoption in CROs for preclinical research, clinical trials, and AI-enabled multi-modal MRI imaging.
• Germany: 1,200 units, 20% share, CROs utilize high-field MRI systems for drug development and imaging studies.
• Japan: 800 units, 13% share, adoption in research-focused CROs and pharmaceutical imaging applications.
• China: 1,000 units, 17% share, CROs integrate high-field and AI-enabled MRI systems for clinical and preclinical studies.
• UK: 500 units, 8% share, CROs deploy multi-modal MRI systems for pharmaceutical and biotech research purposes.

Regional Outlook

The MRI equipment market demonstrates varied regional growth with Asia-Pacific leading 35% of global installations, North America 28%, Europe 25%, and Middle East & Africa 7%. Hospitals account for 70% of total installations, diagnostic centers 20%, and research institutions 10%. High-field 3T MRI systems constitute 45%, 1.5T systems 50%, and ultra-high-field 7T 5% of global installations. AI-enabled imaging is implemented in 20% of units, while urban areas contribute 65% of total deployments. Demand is rising in multi-specialty hospitals, research centers, and diagnostic imaging facilities, reflecting increasing adoption of advanced MRI solutions for clinical and research purposes.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America accounts for 28% of global MRI equipment installations with over 11,000 units deployed in 2024. Hospitals represent 75% of installations, diagnostic centers 20%, and research institutes 5%. High-field 3T MRI systems constitute 40% of total units, 1.5T systems 55%, and ultra-high-field 7T systems 5%. Urban hospitals contribute 60% of installations, while suburban hospitals account for 40%. AI-enabled imaging is integrated in 20% of units. Multi-modal MRI systems such as PET-MRI and fMRI represent 25% of installations. North America leads in adopting advanced imaging solutions for oncology, neurology, cardiology, and musculoskeletal diagnostics.

North America Market Size, Share and CAGR: North America holds 28% market share with 11,000 units, driven by hospitals, diagnostic centers, and research institutes adopting high-field and AI-enabled MRI systems.

North America - Major Dominant Countries

• USA: 8,500 units, 77% share, leading adoption in multi-specialty hospitals, research facilities, and diagnostic centers with high-field MRI systems.
• Canada: 1,500 units, 14% share, urban hospitals and diagnostic centers deploy 3T and 1.5T MRI equipment.
• Mexico: 700 units, 6% share, adoption in hospitals, diagnostic imaging centers, and university research facilities.
• Puerto Rico: 200 units, 2% share, hospital and research institute deployment with high-field and mid-field MRI units.
• Costa Rica: 100 units, 1% share, community hospitals and diagnostic centers adopt low- and mid-field MRI systems.

EUROPE

Europe contributes 25% of global MRI equipment installations with 9,500 units deployed in 2024. Hospitals represent 70%, diagnostic centers 20%, and research institutes 10% of installations. High-field 3T MRI systems account for 45%, 1.5T 50%, and ultra-high-field 7T 5% of units. AI-enabled imaging is implemented in 20% of installations. Urban hospitals contribute 65% of total units, and multi-modal imaging systems such as fMRI and PET-MRI constitute 30% of research institute installations. Germany, UK, France, Italy, and Spain lead the regional market with advanced MRI adoption in clinical and research settings.

Europe Market Size, Share and CAGR: Europe holds 25% market share with 9,500 units, driven by adoption in urban hospitals, diagnostic centers, and research institutes integrating AI-enabled and high-field MRI systems.

Europe - Major Dominant Countries

• Germany: 3,000 units, 32% share, deployment in hospitals, universities, and research institutes for high-field and ultra-high-field MRI applications.
• UK: 2,500 units, 26% share, adoption in urban hospitals and diagnostic imaging centers with AI-enabled MRI systems.
• France: 1,500 units, 16% share, hospitals and research institutes deploy 3T MRI equipment for clinical and research use.
• Italy: 1,200 units, 13% share, high-field MRI adoption in hospitals and universities for neurological and cardiology applications.
• Spain: 800 units, 8% share, hospitals and diagnostic centers integrate AI-enabled and high-resolution MRI systems.

ASIA-PACIFIC

Asia-Pacific dominates with 35% of global MRI equipment installations totaling 18,000 units in 2024. Hospitals account for 70%, diagnostic centers 20%, and research institutes 10% of deployments. High-field 3T MRI systems represent 45% of units, 1.5T systems 50%, and ultra-high-field 7T systems 5%. AI-enabled imaging is integrated into 20% of installations. Urban hospitals account for 65% of deployments, while suburban and semi-urban hospitals account for 35%. China, India, Japan, South Korea, and Australia lead the regional adoption of MRI systems, driven by rising healthcare infrastructure development, advanced diagnostic needs, and research-focused ultra-high-field MRI installations.

Asia-Pacific Market Size, Share and CAGR: Asia-Pacific holds 35% market share with 18,000 units, driven by growing urban hospitals, diagnostic centers, and research institutes adopting high-field and AI-enabled MRI systems.

Asia - Major Dominant Countries

• China: 7,000 units, 39% share, urban hospitals and research institutes adopt high-field and ultra-high-field MRI equipment.
• India: 4,500 units, 25% share, adoption in multi-specialty hospitals and diagnostic centers with AI-enabled MRI systems.
• Japan: 2,500 units, 14% share, hospitals and research institutes deploy high-field MRI systems for clinical and research purposes.
• South Korea: 2,000 units, 11% share, hospitals integrate 3T MRI systems and AI-enabled imaging solutions.
• Australia: 2,000 units, 11% share, urban hospitals and research centers adopt high-field MRI systems with multi-modal imaging.

MIDDLE EAST & AFRICA

Middle East & Africa represents 7% of global MRI equipment installations with 3,600 units deployed in 2024. Hospitals account for 70%, diagnostic centers 20%, and research institutes 10% of deployments. High-field 3T MRI systems constitute 40% of units, 1.5T systems 55%, and ultra-high-field 7T systems 5%. AI-enabled imaging is implemented in 20% of installations. Urban hospitals contribute 60% of installations, while suburban hospitals represent 40%. Countries including UAE, Saudi Arabia, South Africa, Egypt, and Nigeria lead regional MRI adoption, driven by government healthcare initiatives, hospital expansions, and research infrastructure development.

Middle East and Africa Market Size, Share and CAGR: The region holds 7% market share with 3,600 units, driven by adoption in urban hospitals, diagnostic centers, and research institutes integrating high-field and AI-enabled MRI systems.

Middle East and Africa - Major Dominant Countries

• UAE: 1,000 units, 28% share, urban hospitals and private diagnostic centers deploy high-field MRI and AI-enabled systems.
• Saudi Arabia: 900 units, 25% share, adoption in hospitals, research centers, and multi-specialty facilities with 3T MRI systems.
• South Africa: 700 units, 19% share, hospitals and diagnostic centers adopt high-field and 1.5T MRI systems.
• Egypt: 500 units, 14% share, hospitals and research institutes integrate high-field MRI for clinical and research purposes.
• Nigeria: 500 units, 14% share, adoption in urban hospitals and diagnostic centers with low- and mid-field MRI systems.

List of Top MRI Equipment Market Companies

• GE
• Siemens
• Philips
• Toshiba
• Hitachi
• ESAOTE
• SciMedix
• Paramed
• Neusoft
• Xingaoyi
• ANKE
• Huarun Wandong
• Alltech

Top 2 Companies with Highest Market Share

• GE: Holds 18% global market share with 7,200 MRI units installed in 2024, leading in high-field, AI-enabled, and multi-modal imaging systems across hospitals and research centers worldwide.
• Siemens: Captures 16% global market share with 6,400 MRI units installed in 2024, recognized for advanced 3T and 7T MRI systems, AI-enabled imaging, and multi-modal integration for clinical and research applications.

Investment Analysis and Opportunities

The MRI equipment market offers significant investment opportunities due to the rising demand for high-field, AI-enabled, and multi-modal MRI systems. Global installations reached 40,000 units in 2024, with 45% representing high-field 3T MRI, 50% mid-field 1.5T, and 5% ultra-high-field 7T MRI. Hospitals account for 70% of installations, diagnostic centers 20%, and research institutes 10%. Urban hospitals contribute 65% of installations, while suburban facilities account for 35%. Investments in AI imaging, multi-modal PET-MRI and fMRI, and ultra-high-field MRI systems can capture incremental growth, particularly in Asia-Pacific and North America, representing 18,000 and 11,000 units respectively. Expansion in emerging markets, preclinical research institutes, and private diagnostic centers provide opportunities for manufacturers and distributors to enhance market penetration and technological adoption.

New Product Development

Manufacturers are focusing on innovations such as AI-enabled imaging, multi-modal MRI, and patient-centric design. In 2024, 25% of new installations included AI-enabled image reconstruction and automated analysis. Multi-modal PET-MRI and fMRI systems accounted for 30% of research-focused installations. Noise reduction, ergonomic design, and faster scan protocols improved patient comfort and workflow efficiency, adopted in 20% of hospitals. Ultra-high-field 7T MRI systems are increasingly used in academic and research hospitals, representing 5% of total units. Manufacturers are expanding cloud-based imaging software, AI-assisted diagnostics, and advanced coil technologies to enhance clinical and research outcomes, enabling hospitals and research institutes to optimize throughput and diagnostic accuracy.

Five Recent Developments

• GE launched AI-enabled 3T and 7T MRI systems in 2024, representing 25% of new installations globally in hospitals and research centers.
• Siemens introduced multi-modal PET-MRI systems in 2023, deployed in 20% of academic hospitals and research institutes.
• Philips released noise-reduction and patient-centric MRI scanners in 2024, adopted by 15% of urban hospitals and diagnostic centers.
• Hitachi launched mid-field and low-field permanent-magnet MRI systems in 2024 for small hospitals and outpatient clinics, contributing 10% of installations.
• Toshiba upgraded 3T and 1.5T MRI systems with AI-assisted diagnostics in 2025, representing 12% of hospital installations worldwide.

Report Coverage of MRI Equipment Market

This report provides an extensive analysis of the MRI equipment market, covering segmentation by type (superconducting and permanent-magnet) and by application, including hospitals, diagnostic centers, academic institutes, and contract research organizations. It encompasses regional insights across North America, Europe, Asia-Pacific, and Middle East & Africa, highlighting market share, adoption trends, and technological innovations. The report analyzes hospital and diagnostic center deployments, high-field and ultra-high-field MRI systems, AI-enabled and multi-modal imaging solutions, and preclinical research usage. Key manufacturers are profiled with market share, product offerings, and recent developments. Insights include urban vs. suburban adoption, installation trends in academic and research institutions, and emerging opportunities in AI and multi-modal MRI technology.

MRI Equipment Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 6643.01 Million in 2026
Market Size Value By	USD 8296.22 Million by 2035
Growth Rate	CAGR of 2.5% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Superconducting Type MRI Equipment Permanent-magnet Type MRI Equipment By Application : Academic and Research Institutes Biotechnology and Pharmaceutical Companies Diagnostic Centers Contract Research Organizations
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample